Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Dermatologic 2Thoracic 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Ovarian Neoplasms 15Uterine Cervical Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Melanoma 9Triple Negative Breast Neoplasms 7Endometrial Neoplasms 7Stomach Neoplasms 6Carcinoma, Transitional Cell 6Carcinoma, Renal Cell 6Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 5Fallopian Tube Neoplasms 5Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Carcinoma, Hepatocellular 4Neoplasm Metastasis 3Mesothelioma 3Esophageal Neoplasms 3Cholangiocarcinoma 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Seminoma 2Sarcoma 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2

Interventions

Carboplatin 19Paclitaxel 17Cisplatin 9Cyclophosphamide 8Gemcitabine 7Bevacizumab 6Topotecan 5pembrolizumab 4olaparib 4liposomal doxorubicin 4durvalumab 4Letrozole 4Interleukin-2 4Drug Therapy 4Doxorubicin 4Albumin-Bound Paclitaxel 4rucaparib 3fludarabine 3chiauranib 3cemiplimab 3camrelizumab 3Therapeutics 3Itraconazole 3Injections 3Hyperthermic Intraperitoneal Chemotherapy 3Everolimus 3pazopanib 2iniparib 2eprenetapopt 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Ipilimumab × Gynecologic × Clear all
NCT03355976 2026-04-02

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Brown University

Phase 2 Active not recruiting
46 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence, Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡